주식/증권
📈 긍정적
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
요약
PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and higher spending squeeze margins and widen losses.